This is the authors' abstract. We don't add key points for this paper.
Supplementation of Escherichia coli pantothenate auxotrophs with varying concentrations of pantothenate results in a concomitant variation of the intracellular level of CoA but has no effect on the level of holo-[acyl carrier protein] (holo-[ACP]) (Alberts, A., and Vagelos, P. R. (1966) J. Biol. Chem. 241, 5201-5204). The 4-phosphopantetheine moiety of CoA is transferred by the enzyme holo-[ACP] synthase to apo-[acyl carrier protein] (apo-[ACP]) to form holo-[ACP], the form active in lipid synthesis. We mutagenized an E. coli K12 pantothenate auxotroph and selected for mutants unable to grow on a low concentration of pantothenate (0.25 microM) but that grew on a much higher level (25 microM). One of these strains was completely deficient in holo-[ACP] synthase. Reversion and recombinational genetic analyses indicated that the mutant growth phenotype was due to an altered holo-[ACP] synthase activity. The changes in the intracellular levels of CoA and holo-[ACP] engendered by manipulation of the levels of pantothenate supplementation were consistent with a deficiency in holo-[ACP] synthase activity in cultures supplemented with low levels of pantothenate. The site of the genetic lesion (called acpS) was localized on the E. coli genetic map.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Polacco et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: